Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa
Hidradenitis Suppurativa
About this trial
This is an interventional treatment trial for Hidradenitis Suppurativa
Eligibility Criteria
Inclusion Criteria:
- Legally competent women and men
- aged 18 years or older
- Two appropriate HS fistulas
Exclusion Criteria:
- fistulas in areas that have previously received surgery
- Allergy to lidocaine or adrenaline
- Fragile physical health that cannot tolerate standard of care HS rescue therapy
- Pregnant or lactating women
Sites / Locations
- zealand University Hospital RoskildeRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
1470 nm diode laser treatment of right HS-fistula
1470 nm diode laser treatment of left HS-fistula
This is an intra-person study, comparing outcomes within participants. All participants will receive active 1470 nm intra-lesional diode laser treatment on one HS tunnel. Half of the enroled patients will receive active treatment of the right side, while the HS tunnel on the left side will be left as an untreated control.
This is an intra-person study, comparing outcomes within participants. All participants will receive active 1470 nm intra-lesional diode laser treatment on one HS tunnel. Half of the enroled patients will receive active treatment of the left side, while the HS tunnel on the right side will be left as an untreated control.